Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte - Epithelial cell interaction

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 12, 2008, Pages 1823-1833

  Manousou, Pinelopi ^a   Kolios, George ^a   Drygiannakis, Ioannis ^a   Pyrovolaki, Katerina ^a   Bourikas, Leonidas ^a   Papadaki, Helen A ^a   Kouroumalis, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Chemokine receptors; Chemokines; Crohn's disease; CXCR3; Inflammatory bowel disease

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ADULT; ARTICLE; BLOOD LEVEL; CELL INTERACTION; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE MIGRATION; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 57049124169     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05486.x     Document Type: Article

References (48)

1. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 2002 347 : 417 29.
2. Lichtenstein GR. Chemokines and cytokines in inflammatory bowel disease and their application to disease treatment. Curr. Opin. Gastroenterol. 2000 16 : 83 8.
3. Gijsbers K, Geboes K, Van Damme J. Chemokines in gastrointestinal disorders. Curr. Drug Targets 2006 7 : 47 64.
4. Gerard C, Rollins BJ. Chemokines and disease. Nat. Immunol. 2001 2 : 108 15.
5. Sandborn WJ, Colombel JF, Enns R et al. Natalizumab induction and maintenance therapy for Crohn's disease. N. Engl. J. Med. 2005 353 : 1912 25.
6. Sans M, Danese S, de Souza MC et al. Enhanced recruitment of CX3CR1+ T-cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. Gastroenterology 2007 132 : 139 53.
7. Svensson M, Marsal J, Ericsson A et al. CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J. Clin. Invest. 2002 110 : 1113 21.
8. Dubois B, Goubier A, Joubert G, Kaiserlian D. Oral tolerance and regulation of mucosal immunity. Cell. Mol. Life Sci. 2005 62 : 1322 32.
9. Shao L, Serrano D, Mayer L. The role of epithelial cells in immune regulation in the gut. Semin. Immunol. 2001 13 : 163 76.
10. Christ AD, Blumberg RS. The intestinal epithelial cell: immunological aspects. Springer Semin. Immunopathol. 1997 18 : 449 61.
11. Kolios G, Rooney N, Murphy CT, Robertson DA, Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 1998 43 : 56 63.
12. Mudter J, Neurath MF. Mucosal T-CELLs: mediators or guardians of inflammatory bowel disease? Curr. Opin. Gastroenterol. 2003 19 : 343 9.
13. Papadakis KA, Prehn J, Zhu D et al. Expression and regulation of the chemokine receptor CXCR3 on lymphocytes from normal and inflammatory bowel disease mucosa. Inflamm. Bowel. Dis. 2004 10 : 778 88.
14. Kolios G, Wright KL, Jordan NJ, Leithead JB, Robertson DA, Westwick J. C-X-C and C-C chemokine expression and secretion by the human colonic epithelial cell line, HT-29: differential effect of T lymphocyte-derived cytokines. Eur. J. Immunol. 1999 29 : 530 6.
15. Kucharzik T, Hudson JT III., Lugering A et al. Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury. Gut 2005 54 : 1565 72.
16. Dahan S, Roth-Walter F, Arnaboldi P, Agarwal S, Mayer L. Epithelia: lymphocyte interactions in the gut. Immunol. Rev. 2007 215 : 243 53.
17. Farber JM. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 1997 61 : 246 57.
18. Cole KE, Strick CA, Paradis TJ et al. T-cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T-cells through selective high affinity binding to CXCR3. J. Exp. Med. 1998 187 : 2009 21.
19. Hyun JG, Lee G, Brown JB et al. Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm. Bowel. Dis. 2005 11 : 799 805.
20. Piali L, Weber C, LaRosa G et al. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 1998 28 : 961 72.
21. Yuan YH, ten Hove T, The FO, Slors JF, van Deventer SJ, te Velde AA. Chemokine receptor CXCR3 expression in inflammatory bowel disease. Inflamm. Bowel. Dis. 2001 7 : 281 6.
22. Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T-cells associated with certain inflammatory reactions. J. Clin. Invest. 1998 101 : 746 54.
23. Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T-cell recruitment to specific liver compartments within hepatitis C-infected liver. J. Immunol. 1999 163 : 6236 43.
24. Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T-cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA 1999 96 : 6873 8.
25. Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 1996 184 : 963 9.
26. Ehlert JE, Addison CA, Burdick MD, Kunkel SL, Strieter RM. Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J. Immunol. 2004 173 : 6234 40.
27. Lasagni L, Francalanci M, Annunziato F et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 2003 197 : 1537 49.
28. Kelsen SG, Aksoy MO, Yang Y et al. The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells. Am. J. Physiol Lung Cell Mol Physiol 2004 287 : L584 91.
29. Glaser J, Gonzalez R, Perreau VM, Cotman CW, Keirstead HS. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury. J. Neurosci. Res. 2004 77 : 701 8.
30. Strieter RM, Belperio JA, Burdick MD, Keane MP. CXC chemokines in angiogenesis relevant to chronic fibroproliferation. Curr. Drug Targets Inflamm. Allergy 2005 4 : 23 6.
31. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 2004 25 : 201 9.
32. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 1989 170 : 2 6.
33. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976 70 : 439 44.
34. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998 43 : 29 32.
35. Koumaki V, Papadaki HA, Stefanaki K et al. Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia. Ann. Hematol. 2003 82 : 641 5.
36. Papadaki HA, Stamatopoulos K, Damianaki A et al. T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br. J. Haematol. 2005 128 : 863 76.
37. Weaver SA, Russo MP, Wright KL et al. Regulatory role of phosphatidylinositol 3-kinase on TNF-alpha-induced cyclooxygenase 2 expression in colonic epithelial cells. Gastroenterology 2001 120 : 1117 27.
38. Jordan NJ, Kolios G, Abbot SE et al. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest. 1999 104 : 1061 9.
39. Valatas V, Kolios G, Manousou P et al. Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells. Br. J. Pharmacol. 2004 141 : 477 87.
40. Scheerens H, Hessel E, Waal-Malefyt R, Leach MW, Rennick D. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T-cells. Eur. J. Immunol. 2001 31 : 1465 74.
41. Kristensen NN, Gad M, Thomsen AR, Lu B, Gerard C, Claesson MH. CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+. Inflamm. Bowel Dis. 2006 12 : 374 81.
42. Dwinell MB, Lugering N, Eckmann L, Kagnoff MF. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 2001 120 : 49 59.
43. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 2003 199 : 28 35.
44. Mir A, Minguez M, Tatay J et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am. J. Gastroenterol. 2002 97 : 1452 7.
45. Ogawa H, Iimura M, Eckmann L, Kagnoff MF. Regulated production of the chemokine CCL28 in human colon epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 2004 287 : G1062 69.
46. Chen W, Paulus B, Shu D, Wilson I, Chadwick V. Increased serum levels of eotaxin in patients with inflammatory bowel disease. Scand. J. Gastroenterol 2001 36 : 515 20.
47. Sauty A, Dziejman M, Taha RA et al. The T-cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 1999 162 : 3549 58.
48. Cockwell P, Calderwood JW, Brooks CJ, Chakravorty SJ, Savage CO. Chemoattraction of T-cells expressing CCR5, CXCR3 and CX3CR1 by proximal tubular epithelial cell chemokines. Nephrol. Dial. Transpl. 2002 17 : 734 44.